Quanterix: Masoud Toloue, Kevin Hrusovksy

Masoud Toloue will become CEO of Quanterix, effective April 25, taking over from Kevin Hrusovsky, who will assume the role of executive chairman of the board. Toloue, who will also join the firm's board of directors, is currently president of Quanterix and diagnostics. Previously, he was senior VP of diagnostics at PerkinElmer, and before that, he founded and led the next-generation sequencing business of Bioo Scientific, a company acquired by PerkinElmer in 2016. He holds a PhD in molecular cell biology from the University at Buffalo.